Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moulin

Showing results (111-120 of 188) with videos related to

Pageof 19
Sort By:
Archives of Cardiovascular Diseases|February 6, 2026
Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)Benjamin Bouillet, Romain Boulestreau, Victor Aboyans, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2013
Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemiaCatherine Calzada, Evelyne Véricel, Romain Colas, et al.
Lipids|August 13, 2010
Increased lipid peroxidation in LDL from type-2 diabetic patientsRomain Colas, Valérie Pruneta-Deloche, Michel Guichardant, et al.
Diabetes Care|March 1, 2006
Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind studyPhilippe Moulin, Marie Andre, Hasan Alawi, et al.
Plos One|June 23, 2012
Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitusGeneviève Derumeaux, Laura Ernande, André Serusclat, et al.
American Journal of Human Genetics|January 7, 2014
An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding siteCyrielle Caussy, Sybil Charrière, Christophe Marçais, et al.
Journal of Clinical Lipidology|October 11, 2020
Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemiaMarine Serveaux Dancer, Oriane Marmontel, Anne-Sophie Wozny, et al.
Clinical Chemistry and Laboratory Medicine|July 29, 2024
Evaluation of biochemical algorithms to screen dysbetalipoproteinemia in ε2ε2 and rare <i>APOE</i> variants carriersLouise Michenaud, Nathanaël Marrié, Antoine Rimbert, et al.
Atherosclerosis|March 22, 2021
Taking action: European Atherosclerosis Society targets the United Nations Sustainable Development Goals 2030 agenda to fight atherosclerotic cardiovascular disease in EuropePaolo Parini, Ruth Frikke-Schmidt, Alexandros D Tselepis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2025
Course of Pregnancies and Occurrence of Acute Pancreatitis in Women with ChylomicronemiaMiriam Larouche, Jean Bergeron, Diane Brisson, et al.
Pageof 19

Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Archives of Cardiovascular Diseases|February 6, 2026
Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)Benjamin Bouillet, Romain Boulestreau, Victor Aboyans, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2013
Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemiaCatherine Calzada, Evelyne Véricel, Romain Colas, et al.
Lipids|August 13, 2010
Increased lipid peroxidation in LDL from type-2 diabetic patientsRomain Colas, Valérie Pruneta-Deloche, Michel Guichardant, et al.
Diabetes Care|March 1, 2006
Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind studyPhilippe Moulin, Marie Andre, Hasan Alawi, et al.
Plos One|June 23, 2012
Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitusGeneviève Derumeaux, Laura Ernande, André Serusclat, et al.
American Journal of Human Genetics|January 7, 2014
An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding siteCyrielle Caussy, Sybil Charrière, Christophe Marçais, et al.
Journal of Clinical Lipidology|October 11, 2020
Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemiaMarine Serveaux Dancer, Oriane Marmontel, Anne-Sophie Wozny, et al.
Clinical Chemistry and Laboratory Medicine|July 29, 2024
Evaluation of biochemical algorithms to screen dysbetalipoproteinemia in ε2ε2 and rare <i>APOE</i> variants carriersLouise Michenaud, Nathanaël Marrié, Antoine Rimbert, et al.
Atherosclerosis|March 22, 2021
Taking action: European Atherosclerosis Society targets the United Nations Sustainable Development Goals 2030 agenda to fight atherosclerotic cardiovascular disease in EuropePaolo Parini, Ruth Frikke-Schmidt, Alexandros D Tselepis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2025
Course of Pregnancies and Occurrence of Acute Pancreatitis in Women with ChylomicronemiaMiriam Larouche, Jean Bergeron, Diane Brisson, et al.
Pageof 19